HUTCHMED (00013): Executive Director and Chief Financial Officer Chi-chung Cheng appointed as acting Chief Executive Officer.

date
25/08/2025
avatar
GMT Eight
Huahuang Medicine (00013) issued an announcement that the Board of Directors was informed that the executive director of the company, Mr. Su Weiguo, will temporarily suspend his duties due to health reasons...
HUTCHMED (00013) announced that the Board of Directors has been informed that the Company's Executive Director, Mr. Su Weiguo, will temporarily suspend his duties as Chief Executive Officer for health reasons. In light of this, the Board of Directors has appointed Mr. Zhou Zefeng, the Company's Executive Director and Chief Financial Officer, to serve as Acting Chief Executive Officer with immediate effect. In addition to his role as Chief Financial Officer, Mr. Zhou will also be responsible for overseeing the Company's daily operations and management during the transition period to ensure the continuity of the Company's leadership and decision-making.